Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

Mes dernières consult.
Most popular
Delayed Quote. Delayed  - 06/22 05:32:00 pm
219.85 CHF   +2.02%
06/22Roche to Appoint James Sabry as Head of Partnering
06/20Roche to Buy Rest of Cancer Firm -- WSJ
06/20Latecomer Sanofi looks to catch next wave of cancer therapies
Analysis summary4-Traders Strategies
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Ulrich Ebensperger

Financial Analyst
share with twitter share with LinkedIn share with facebook
share via e-mail

An opportunity over the medium term?

Strategy published on 11/08/2016 | 08:59
long trade
Stop-loss triggered
Entry price : 224.9CHF | Target : 280CHF | Stop-loss : 218CHF | Potential : 24.5%
Roche Holding Ltd. shares have returned to important technical levels around 220.1 CHF based on weekly price data. The timing seems attractive to be a buyer of this stock.
Investors have an opportunity to buy the stock and target the CHF 280.
  • The share is getting closer to its long-term support in weekly data, at CHF 217.3, which offers good timing for buyers.
  • Share prices are approaching a strong support area in daily data, which offers good timing for investors.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The company is in a robust financial situation considering its net cash and margin position.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

  • The group usually releases earnings worse than estimated.
  • The company's enterprise value to sales, at 3.88 times its current sales, is high.
  • The technical configuration over the long term remains negative on the weekly chart below the resistance level at 245.5 CHF
share with twitter share with LinkedIn share with facebook
share via e-mail
Recevoir les alertes

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials ( CHF)
Sales 2018 55 696 M
EBIT 2018 18 523 M
Net income 2018 12 023 M
Debt 2018 4 036 M
Yield 2018 3,94%
P/E ratio 2018 15,25
P/E ratio 2019 14,67
EV / Sales 2018 3,48x
EV / Sales 2019 3,29x
Capitalization 190 B
Surperformance© ratings
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
Duration : Period : Day
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Duration : Period : Week
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders